Together, these results suggest that CYP2J2 overexpression protects against development of cardiac hypertrophy and cardiac remodeling and that CYP2J2‐mediated cardioprotection is accompanied by an increase in ANP expression. The gene discussed is NPPA; the disease is cardiac hypertrophy.